Related Experiment Videos
Surgery for severe COPD. Lung volume reduction and lung transplantation
1Department of Medicine, Temple University School of Medicine, Philadelphia 19141, USA. jerryo@astro.ocis.temple.edu
Postgraduate Medicine
|April 29, 1998
Summary
Lung volume reduction surgery (LVRS) offers functional improvement for severe emphysema patients, with fewer risks than lung transplantation. Further research is needed to confirm its survival benefits compared to standard care.
Area of Science:
- Pulmonology
- Thoracic Surgery
- Critical Care Medicine
Background:
- Severe emphysema management presents challenges, with limited treatment options impacting patient quality of life.
- Lung volume reduction surgery (LVRS) and lung transplantation are considered for advanced cases, each with distinct risk-benefit profiles.
Purpose of the Study:
- To outline a management strategy for severe emphysema, comparing LVRS and lung transplantation.
- To discuss the potential benefits and limitations of LVRS in a broader patient population compared to lung transplantation.
Main Methods:
- Review of current management strategies for severe emphysema.
- Comparison of physiological improvements, availability, and risks associated with LVRS and lung transplantation.
Main Results:
- LVRS demonstrates potential for functional improvement in more patients due to wider availability and lower attendant risks than lung transplantation.
- Physiological improvements from LVRS are generally less than those from lung transplantation.
Conclusions:
- LVRS may improve functional performance in a larger severe emphysema patient group without transplantation risks.
- Lung transplantation should be reserved for patients unsuitable or too ill for LVRS.
- Further research, including the NETT trial, is crucial to determine LVRS efficacy over standard therapy for survival and physiological variables.